All articles by Manish Kumar
Manish Kumar
Revolution in real time: Exo introduces SweepAI — ultrasound just got smarter
Redefining the way you scan, Exo Iris gets four new FDA-cleared SweepAI-powered applications
ZOLL recruits first patient in SSO2 therapy trial in LAD STEMI heart attacks
The SSCORE study will evaluate SSO2 Therapy’s impact on heart failure and mortality in LAD STEMI patients while assessing potential healthcare cost savings
IDT debuts new Archer VARIANTPlex Lymphoma panel for cancer research
The customisable Archer VARIANTPlex Lymphoma panel is intended to detect single nucleotide variants, insertions, deletions, and copy number variations for B-cell and T-cell lymphoma research
Synergia Medical successfully implants first patients with NAO.VNS
These first-in-human implantations took place on September 6, 2024, at Cliniques Universitaires Saint-Luc and UZ Gent
Hyperfine announces promising interim findings on the value of portable, ultra-low-field MR imaging for acute stroke care
The Swoop Portable MR Imaging system shows faster time-to-scan compared to conventional MRI and good specificity in emergency stroke care
ClaroNav gets FDA’s expanded approval for Navident EVO system
Navident EVO is designed to enhance precision in hard-tissue dental surgeries using advanced navigation and real-time guidance to offer minimally invasive access for dentists and patients
Genetesis’ CardioFlux MCG gets Health Canada approval for myocardial ischemia
The approval was based on results from MAGNETO and MICRO studies which showed the device’s ability to enhance diagnostic accuracy without using contrast agents, radiation, or stress-inducing pharmaceuticals
Stryker completes acquisition of NICO Corporation, expanding minimally invasive solutions for brain tumor removal and stroke care
This acquisition further strengthens Stryker’s commitment to neurotechnology through tumor and stroke care
World first blood test for esophageal cancer shows 94% accuracy in clinical validation study
Proteomics International’s novel PromarkerEso blood test for esophageal adenocarcinoma shows 94% accuracy in clinical validation study
GE HealthCare introduces tablet-based Venue Sprint POCUS device
Venue Sprint, the latest portable solution in the Venue family, features advanced scanning capabilities and wireless integration with Vscan Air probes for point-of-care support